Diabetes 'technological wave' has too much upside to ignore: JP Morgan

New technologies for diabetes treatment are becoming essential, according to J.P. Morgan, with companies like Dexcom presenting compelling investment opportunities.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.